These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18767044)

  • 1. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
    Giulianelli S; Cerliani JP; Lamb CA; Fabris VT; Bottino MC; Gorostiaga MA; Novaro V; Góngora A; Baldi A; Molinolo A; Lanari C
    Int J Cancer; 2008 Dec; 123(11):2518-31. PubMed ID: 18767044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth.
    Fabris VT; Sahores A; Vanzulli SI; Colombo L; Molinolo AA; Lanari C; Lamb CA
    BMC Cancer; 2010 Jun; 10():293. PubMed ID: 20553594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
    Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
    Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.
    Giulianelli S; Herschkowitz JI; Patel V; Lamb CA; Gutkind JS; Molinolo A; Perou CM; Lanari C
    Breast Cancer Res Treat; 2011 Aug; 129(1):49-67. PubMed ID: 20890655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.
    Diep CH; Spartz A; Truong TH; Dwyer AR; El-Ashry D; Lange CA
    Endocrinology; 2024 Jul; 165(9):. PubMed ID: 39041201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
    Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
    Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
    Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
    Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors.
    Viegas MH; Salatino M; Goin M; Peters G; Labriola L; Costa da cunha J; Lanari C; Charreau EH; Elizalde PV
    Cancer Detect Prev; 1999; 23(5):375-86. PubMed ID: 10468889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
    Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
    Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
    J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
    Reyes D; Ballaré C; Castellano G; Soronellas D; Bagó JR; Blanco J; Beato M
    Oncogene; 2014 Mar; 33(12):1570-80. PubMed ID: 23604116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride.
    Wiebe JP; Rivas MA; Mercogliano MF; Elizalde PV; Schillaci R
    J Steroid Biochem Mol Biol; 2015 May; 149():27-34. PubMed ID: 25595041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
    Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
    Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
    Lamb CA; Fabris V; Gorostiaga MA; Helguero LA; Efeyan A; Bottino MC; Simian M; Soldati R; Sanjuan N; Molinolo A; Lanari C
    J Cell Physiol; 2005 Mar; 202(3):672-82. PubMed ID: 15389583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.